KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent Deferred RevenueDividends payablesLand & ImprovementsLiabilities and Shareholders EquityLoans - NetMinority InterestOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Accounts Payables: 2009-2025

Historic Accounts Payables for National Health Investors (NHI) over the last 14 years, with Jun 2025 value amounting to $33.0 million.

  • National Health Investors' Accounts Payables fell 0.46% to $33.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $33.0 million, marking a year-over-year decrease of 0.46%. This contributed to the annual value of $37.8 million for FY2024, which is 10.07% up from last year.
  • Per National Health Investors' latest filing, its Accounts Payables stood at $33.0 million for Q2 2025, which was up 13.21% from $29.2 million recorded in Q1 2025.
  • In the past 5 years, National Health Investors' Accounts Payables registered a high of $33.2 million during Q2 2024, and its lowest value of $19.1 million during Q1 2022.
  • For the 3-year period, National Health Investors' Accounts Payables averaged around $29.7 million, with its median value being $29.3 million (2023).
  • In the last 5 years, National Health Investors' Accounts Payables slumped by 35.02% in 2021 and then grew by 28.85% in 2023.
  • Quarterly analysis of 5 years shows National Health Investors' Accounts Payables stood at $20.9 million in 2021, then rose by 10.11% to $23.0 million in 2022, then climbed by 27.52% to $29.3 million in 2023, then climbed by 10.85% to $32.5 million in 2024, then fell by 0.46% to $33.0 million in 2025.
  • Its last three reported values are $33.0 million in Q2 2025, $29.2 million for Q1 2025, and $32.5 million during Q3 2024.